Genzyme to let Sanofi-Aventis conduct due diligence
This article was originally published in Scrip
Executive Summary
Genzyme says that ongoing discussions with Sanofi-Aventis have progressed to the point where Genzyme's board has authorised the company to enter into a confidentiality agreement to allow Sanofi-Aventis to conduct due diligence.